More Web Proxy on the site http://driver.im/

Dasatinib in breast cancer: Src-ing for response in all the wrong kinases

Ann Transl Med. 2018 Nov;6(Suppl 1):S60. doi: 10.21037/atm.2018.10.26.

Authors

Laura C Kennedy^{1

2}, Vijayakrishna Gadi^{1

2}

Affiliations

¹ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
² Department of Medicine, University of Washington, Seattle, WA, USA.

No abstract available

Publication types

Editorial
Comment

Grants and funding

T32 CA009515/CA/NCI NIH HHS/United States